🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Ischemic strokes account for more than 80% of strokes. Ischemic strokes are...
Status
Terminated
Location
Mikaël Mazighi
Start Date
2019-01-15
Trial ID
NCT04180826
Treatments Being Tested
The overall purpose of this study is to objectively describe and test the c...
Status
Completed
Location
Indiana University
Start Date
2021-05-11
Trial ID
NCT04923633
Treatments Being Tested
Emergency medical service (EMS) vehicles are exposed to a wide range of env...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-01
Trial ID
NCT07646964
Obstructive Sleep Apnea Syndrome (OSAS) is a sleep related breathing disord...
Status
Recruiting
Location
IRCCS San Raffaele Hospital - Sleep Disorders Center
Start Date
2024-03-13
Trial ID
NCT06677580
This is a prospective observational cohort study of adult patients admitted...
Status
Not Yet Recruiting
Location
UT Southwestern Medical Center - Clements University Hospital NSICU
Start Date
2026-07
Trial ID
NCT07577713
Remimazolam is a novel drug approved for induction and maintenance of gener...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2021-11-01
Trial ID
NCT05025410
Treatments Being Tested
The goal of this prospective, multinational, multicenter observational stud...
Status
Recruiting
Location
Medical University of Vienna
Start Date
2025-02-25
Trial ID
NCT06351670
Knee osteoarthritis (OA) is the most common form of arthritis and the most ...
Status
Completed
Location
The University of Nottingham, City Hospital Campus
Start Date
2020-11-06
Trial ID
NCT04443452
The risk associated with arterial hypotension during general anesthesia for...
Status
Unknown
Location
Joaquim MATEO
Start Date
2023-07-20
Trial ID
NCT05803876
Treatments Being Tested
Linezolid is the second line agent in the treatment of MRSA and PRSP infect...
Status
Unknown
Location
National Taiwan University Hospital
Start Date
2016-11-01
Trial ID
NCT03126890